The prognostic value of pharmacologic stress myocardial perfusion imaging in patients with permanent pacemakers

Journal of Nuclear Cardiology

Volumn 12, Issue 1, 2005, Pages 37-42

  Lapeyre III, André C ^a   Poornima, Indu G ^a   Miller, Todd D ^a   Hodge, David O ^a   Christian, Timothy F ^a   Gibbons, Raymond J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adenosine; Dipyridamole; Myocardial perfusion imaging; Permanent pacemaker; Single photon emission computed tomography; Technetium 99m sestamibi; Thallium 201

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; EXERCISE TEST; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADENOSINE; AGED; CARDIAC PACING, ARTIFICIAL; DIPYRIDAMOLE; EXERCISE TEST; FEMALE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PACEMAKER, ARTIFICIAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 12744275013     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2004.08.004     Document Type: Article

References (27)

1. 1. Tawarahara K, Kurata C, Taguchi T, Kobayashi A, Yamazaki N. Exercise testing and thallium-201 emission computed tomography in patients with intraventricular conduction disturbances. Am J Cardiol 1992;69:97-102
2. Abe M, Hamada M, Matsuoka H, et al. Relation between postpacing T wave changes and myocardial scintigraphic characteristics in patients with ventricular demand pacemaker. Angiology 1995;46:489-95
3. Lakkis NM, He ZX, Verani MS. Diagnosis of coronary artery disease by exercise thallium-201 tomography in patients with a right ventricular pacemaker. J Am Coll Cardiol 1997;29:1221-5
4. Ciaroni S, Bloch A, Albrecht L, Vanautryve B. Diagnosis of coronary artery disease in patients with permanent cardiac pacemaker by dobutamine stress echocardiography or exercise thallium-201 myocardial tomography. Echocardiography 2000;17:675-9
5. O'Keefe JH Jr, Bateman TM, Silvestri R, Barnhart C. Safety and diagnostic accuracy of adenosine thallium-201 scintigraphy in patients unable to exercise and those with left bundle branch block. Am Heart J 1992 124 614-21
6. Chikamori T, Doi YL, Yonezawa Y, et al. Value of dipyridamole thallium-201 imaging in noninvasive differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction. Am J Cardiol 1992;69:650-3
7. Ebersole DG, Heironimus J, Toney MO, Billingsley J. Comparison of exercise and adenosine technetium-99m sestamibi myocardial scintigraphy for diagnosis of coronary artery disease in patients with left bundle branch block. Am J Cardiol 1993;71:450-3
8. O'Keefe JH Jr, Bateman TM, Barnhart CS. Adenosine thallium-201 is superior to exercise thallium-201 for detecting coronary artery disease in patients with left bundle branch block. J Am Coll Cardiol 1993 21 1332-8
9. Wagdy HM, Hodge D, Christian TF, Miller TD, Gibbons RJ. Prognostic value of vasodilator myocardial perfusion imaging in patients with left bundle-branch block. Circulation 1998;97:1563-70
10. Ortega A, Moreno R, Alonso JC, et al. Utility of SPECT with 99m Tc-tetrofosmin and stimulus with dipyridamole in patients with permanent ventricular pacemakers. [in Spanish]. Rev Esp Med Nucl 2001;20:90-5
11. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318-33
12. Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina) [published erratum appears in J Am Coll Cardiol 1999;34:314]. J Am Coll Cardiol 1999;33:2092-197
13. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-68
14. Johnston DL, Daley JR, Hodge DO, Hopfenspirger MR, Gibbons RJ. Hemodynamic responses and adverse effects associated with adenosine dipyridamole pharmacologic stress testing: A comparison in 2,000 patients. Mayo Clin Proc 1995;70:331-6
15. O'Connor MK, Miller TD, Christian TF, Gibbons RJ. Tc99m sestamibi first-pass radionuclide angiogram. In: O'Connor MK, editor. The Mayo Clinic manual of nuclear medicine. New York: Churchill Livingstone; 1996. p. 197-203
16. Christian TF, Miller TD, Bailey KR, Gibbons RJ. Noninvasive identification of severe coronary artery disease using exercise tomographic thallium-201 imaging. Am J Cardiol 1992;70:14-20
17. Cox DR. Regression models and life-tables. J R Stat Soc [Ser B] 1972;34:187-202.
18. Hubbard BL, Gibbons RJ, Lapeyre AC III, Zinsmeister AR, Clements IP. Identification of severe coronary artery disease using simple clinical parameters. Arch Int Med 1992;152:309-12
19. Jelic V, Belkic K, Djordjevic M, Kocovic D. Survival in 1,431 pacemaker patients: Prognostic factors and comparison with the general population. Pacing Clin Electrophysiol 1992;15:141-7
20. Otterstad JE, Selmer R, Strom O. Prognosis in cardiac pacing. A comparison between patients with atrioventricular block and sick sinus syndrome. Acta Med Scand 1981;210:47-52
21. Stoney WS, Finger FE, Alford WC Jr, et al. The natural history of long-term cardiac pacing. Ann Thorac Surg 1977;23:550-4
22. Jahangir A, Shen WK, Neubauer SA, et al. Relation between mode of pacing and long-term survival in the very elderly. J Am Coll Cardiol 1999;33:1208-16
23. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14
24. Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography [published erratum appears in J Am Coll Cardiol 1996;27:756]. J Am Coll Cardiol 1995;26:639-47
25. Packer M, Colucci WS, Sackner-Bernstein JD, et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise [comment] Circulation 1996;94:2793-9
26. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987;316:1429-35
27. Bernstein AD, Parsonnet V. Survey of cardiac pacing and defibrillation in the United States in 1993. Am J Cardiol 1996;78:187-96